Newsmeme!
Discover News you didn't know existed
(ARA) - After a routine blood test in 2001, Helen Anbinder, now 67, of Dobbs Ferry, N.Y., heard the dreaded words: You have cancer. The diagnosis was chronic lymphocytic leukemia (CLL), a serious blood cancer that affects more than 90,000 people in the United States.
Amgen announced that a pivotal, phase-3, head-to-head trial evaluating denosumab versus Zometa (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The reduction in customs duty of life saving drugs in the Union Budget 2009-10 has not enthused the members of the Indian biotech industry. They are of the view that the move can mainly help the multinational drug companies.
Çѹ·Õè 10 ¡Ã¡®Ò¤Á 2552 08:20 ¹. - Belgian Acquisition Means Novasep Offers Full-Range of Biomanufacturing Solutions Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces today the acquisition of Henogen, a contract manufacturing organization (CMO) offering bioprocess development and manufacturing services ...
Cookie dough samples don't match E coli outbreak strain The US Food and Drug Administration (FDA) today confirmed that the Escherichia coli O157:H7 strain found in an unopened package of cookie dough at Nestle's Danville, Va., plant does not match the genetic fingerprint in the multistate outbreak, ABC News reported today.
THURSDAY, July 9 (HealthDay News) -- An arthritis therapy appears to increase the risk of tuberculosis in certain patients, French researchers have found.
But researchers still don't know why a certain therapy appears to reactivate latent TB
Title: New Drug Fights Anthrax Toxin Category: Health News Created: 7/9/2009 7:00:00 AM Last Editorial Review: 7/9/2009
PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Administration has completed its review of the Company's proposed development plan for SparVax, PharmAthene's next generation recombinant protective antigen anthrax vaccine.
Multiple copies of the MPER of HIV-1 gp41 arrayed on HBsAg particles could significantly increase the immunogenic potential compared to monomeric molecules.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |